- Home
- CWK vs TWST Comparison
CWK vs TWST Comparison
Compare CWK & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWK
- TWST
- Stock Information
- Founded
- CWK 1784
- TWST 2013
- Country
- CWK United States
- TWST United States
- Employees
- CWK N/A
- TWST N/A
- Industry
- CWK Real Estate
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CWK Finance
- TWST Health Care
- Exchange
- CWK Nasdaq
- TWST Nasdaq
- Market Cap
- CWK 1.9B
- TWST 2.3B
- IPO Year
- CWK 2018
- TWST 2018
- Fundamental
- Price
- CWK $10.24
- TWST $32.61
- Analyst Decision
- CWK Hold
- TWST Buy
- Analyst Count
- CWK 7
- TWST 10
- Target Price
- CWK $12.93
- TWST $49.10
- AVG Volume (30 Days)
- CWK 3.3M
- TWST 1.2M
- Earning Date
- CWK 04-29-2025
- TWST 05-05-2025
- Dividend Yield
- CWK N/A
- TWST N/A
- EPS Growth
- CWK 1337.16
- TWST N/A
- EPS
- CWK 0.69
- TWST N/A
- Revenue
- CWK $9,546,300,000.00
- TWST $347,680,000.00
- Revenue This Year
- CWK $5.32
- TWST $22.54
- Revenue Next Year
- CWK $5.06
- TWST $17.77
- P/E Ratio
- CWK $14.37
- TWST N/A
- Revenue Growth
- CWK 1.24
- TWST 25.30
- 52 Week Low
- CWK $7.64
- TWST $29.76
- 52 Week High
- CWK $16.11
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- CWK 61.73
- TWST 35.96
- Support Level
- CWK $9.80
- TWST $31.56
- Resistance Level
- CWK $10.19
- TWST $42.07
- Average True Range (ATR)
- CWK 0.34
- TWST 2.54
- MACD
- CWK 0.25
- TWST -0.56
- Stochastic Oscillator
- CWK 95.27
- TWST 9.99
About CWK Cushman & Wakefield plc
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.